Cargando…

Targeting glial metabolism in neurodegenerative diseases: detail matters

Detalles Bibliográficos
Autores principales:	Afridi, Ruqayya, Suk, Kyoungho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360104/ https://www.ncbi.nlm.nih.gov/pubmed/37282464 http://dx.doi.org/10.4103/1673-5374.371358

Ejemplares similares

The Function of Glial Cells in the Neuroinflammatory and Neuroimmunological Responses
por: Afridi, Ruqayya, et al.
Publicado: (2022)

Metabolic Regulation of Glial Phenotypes: Implications in Neuron–Glia Interactions and Neurological Disorders
por: Afridi, Ruqayya, et al.
Publicado: (2020)

Function of Glial Cells in Neuroinflammatory and Neuroimmunological Responses II
por: Afridi, Ruqayya, et al.
Publicado: (2023)

Microglial Responses to Stress-Induced Depression: Causes and Consequences
por: Afridi, Ruqayya, et al.
Publicado: (2023)

Neuroinflammatory Basis of Depression: Learning From Experimental Models
por: Afridi, Ruqayya, et al.
Publicado: (2021)

Glial interference: impact of type I interferon in neurodegenerative diseases
por: Roy, Ethan, et al.
Publicado: (2022)

Microglia Gone Awry: Linking Immunometabolism to Neurodegeneration
por: Afridi, Ruqayya, et al.
Publicado: (2020)

Human-yeast genetic interaction for disease network: systematic discovery of multiple drug targets
por: Suk, Kyoungho
Publicado: (2017)

Is glial heme oxygenase-1 suppression in neurodegenerative disorders permissive for neural repair?
por: Schipper, Hyman M.
Publicado: (2015)

Glial phenotype modulators
por: Suk, Kyoungho
Publicado: (2017)

Microglia-targeting nanotherapeutics for neurodegenerative diseases
por: Zhao, Nanxia, et al.
Publicado: (2020)

Impact of the metabolic syndrome on the evolution of neurodegenerative diseases
por: de A. Boleti, Ana Paula, et al.
Publicado: (2020)

Targeting mechanisms in cognitive training for neurodegenerative diseases
por: Venneri, Annalena, et al.
Publicado: (2020)

Role of myelin sheath energy metabolism in neurodegenerative diseases
por: Ravera, Silvia, et al.
Publicado: (2015)

Metabolic reprogramming of glial cells as a new target for central nervous system axon regeneration
por: Walden, Erin L., et al.
Publicado: (2021)

Free ubiquitin: a novel therapeutic target for neurodegenerative diseases
por: Park, Chul-Woo, et al.
Publicado: (2021)

Pyruvate Dehydrogenase Kinases in the Nervous System: Their Principal Functions in Neuronal-glial Metabolic Interaction and Neuro-metabolic Disorders
por: Jha, Mithilesh Kumar, et al.
Publicado: (2012)

Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative Diseases
por: Song, Gyun Jee, et al.
Publicado: (2017)

ATP-binding cassette transporters as possible targets for the intervention of neurodegenerative diseases
por: Lok, Hiu Chuen, et al.
Publicado: (2023)

Targeting the epigenome to treat neurodegenerative diseases or delay their onset: a perspective
por: Coppedè, Fabio
Publicado: (2022)

Neuroinflammation and glial activation in the central nervous system: a metabolic perspective
por: Virtuoso, Assunta, et al.
Publicado: (2022)

Unexpected role of complement component 8 gamma chain in the inflamed brain
por: Kim, Jong-Heon, et al.
Publicado: (2023)

Nuclear sphingomyelin in neurodegenerative diseases
por: Albi, Elisabetta, et al.
Publicado: (2021)

Abnormal metal homeostasis as a common drug target to combat neurodegenerative diseases
por: Pretsch, Dagmar
Publicado: (2021)

Nucleoredoxin-like 2 metabolic signaling impairs its potential contribution to neurodegenerative diseases
por: Corsi, Mariangela, et al.
Publicado: (2022)

Tayloring cell populations for neurodegenerative diseases
por: Fortin, Jeff M., et al.
Publicado: (2016)

Significance of intercellular communication for neurodegenerative diseases
por: Cihankaya, Hilal, et al.
Publicado: (2021)

Overcoming mitochondrial dysfunction in neurodegenerative diseases
por: Pessoa, João, et al.
Publicado: (2022)

Implications of glial nitric oxide in neurodegenerative diseases
por: Yuste, Jose Enrique, et al.
Publicado: (2015)

Metabolic checkpoints in neurodegenerative T helper 17 (T(H)17) and neuroregenerative regulatory T (T(reg)) cells as new therapeutic targets for multiple sclerosis
por: Shen, Hongxing, et al.
Publicado: (2019)

Enterovirus infection and its relationship with neurodegenerative diseases
por: Sousa, Ivanildo Pedro, et al.
Publicado: (2023)

Insights into the protective role of immunity in neurodegenerative disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Protection against neurodegenerative disease on Earth and in space
por: Takamatsu, Yoshiki, et al.
Publicado: (2016)

Polyglutamine diseases: looking beyond the neurodegenerative universe
por: Mielcarek, Michal, et al.
Publicado: (2020)

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
por: Jiang, Ziying, et al.
Publicado: (2022)

Therapeutic potential of lysosomal cathepsins for neurodegenerative diseases
por: Prieto Huarcaya, Susy, et al.
Publicado: (2022)

Glial plasticity after hexahydrobenzene exposure
por: Campos-Ordonez, Tania, et al.
Publicado: (2016)

Anti-inflammatory properties of the glial scar
por: Gesteira, Tarsis F., et al.
Publicado: (2016)

Disease-associated oligodendrocyte signatures in neurodegenerative disease: the known and unknown
por: Schuster, Kristen H., et al.
Publicado: (2023)

Therapeutic induction of autophagy to modulate neurodegenerative disease progression
por: Hochfeld, Warren E, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_udci8ts0i2224289eh89mtd2ek